Verdiva Bio

Biotech · Private

Oral GLP-1 and amylin analog therapeutics for cardiometabolic disorders and obesity

verdivabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1619Repair Biotechnologies, Inc.—$25M
1620REELIN THERAPEUTICS, INC.——
1621DASFANH BIOSCIENCES, LLC——
1622Verdiva Bio——
1623Furtim Therapeutics LLC——
1624NOVALEX THERAPEUTICS, INC.——
1625RADIKAL THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.